Compare Cardinal Health Inc (CAH) vs Home Depot Inc (HD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Home Depot Inc — how do they compare? Cardinal Health Inc trades at $237.44 (market cap $55.88B), while Home Depot Inc trades at $346.26 (market cap $353.46B). The key difference: Home Depot Inc is far larger — about 6.3× Cardinal Health Inc's market cap, and Home Depot Inc pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| CAH | HD | |
|---|---|---|
Market Cap | $55.88B | $353.46B |
Sector | Health | Consumer Cyclical |
52-Week High | $240.26 | $423.42 |
52-Week Low | $146.04 | $297.51 |
Enterprise Value | $59.91B | $415.01B |
Dividend Yield | 0.86% | 2.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $237.18, up 0.33% on the day, near its 52-week high. The stock shows bullish technical signals with consistent earnings beats, including Q2 2026 EPS of $2.91 versus $2.42 expected. Revenue reached $222.58 billion in 2025, with net income margin improving to 0.67%. Positive sentiment is driven by strong Q4 2026 results and optimistic fiscal 2027 guidance highlighted by Reuters on August 11, 2026.
Outlook remains favorable with analyst consensus price target of $266.43 implying 12% upside. Key opportunities include pharmaceutical segment strength and dividend payments, while risks involve high debt levels and thin profit margins. The bullish analyst stance (54.55% buy ratings) supports growth potential, but investors should monitor cash flow volatility and competitive pressures.
Home Depot (HD) trades at $350.78, down 1.36% on the day, with a bullish technical outlook supported by moving averages. The company reported mixed quarterly earnings, missing in Q3 2025 but beating in Q4 2025 and Q1 2026. Strong profitability metrics include a 33.13% gross margin and 128.38% ROE, though net margins have declined from 10.87% in 2022 to 8.41% in 2026. Recent news highlights institutional trading activity and concerns about weakening big-ticket demand amid rising mortgage rates.
The stock offers a 6% upside to the consensus price target of $371.25, with 59% of analysts rating it Buy. Key risks include housing market sensitivity and margin pressure from investments. Long-term growth drivers include Pro customer focus and digital expansion, but near-term headwinds from economic conditions warrant caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
